Trial Profile
Open Labeled, Non-randomized, Study of Efficacy and Safety of Gralise in Fibromyalgia Patients.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 22 Nov 2018
Price :
$35
*
At a glance
- Drugs Gabapentin (Primary)
- Indications Fibromyalgia
- Focus Therapeutic Use
- 05 Mar 2014 New trial record